ML234

N/A

Report date: 2024/09/20 14:48:05
NME

Base Information

Drug NameML234
Drug Alias NameML234ML-234
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitorsLysine-specific histone demethylase 1 inhibitors
TargetsHistone-lysine N-methyltransferase EZH2Lysine-specific histone demethylase 1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSun Yat-Sen UniversityGuangdong Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Medical UniversitySun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A